Cardiopulmonary conditions are a major burden on healthcare systems, with one in two seniors suffering from heart or lung conditions. Established in 2015, NuvoAir Medical offers a digital healthcare platform to help improve the level of care for patients suffering from these conditions.
NuvoAir Medical has developed a range of services to improve patient lung health. It delivers in-depth data analysis of remotely-collected biomarkers to drive clinical decision-making. This contributes to a decrease in hospitalizations and a greatly increased quality of life for patients.
The value of this offering has seen NuvoAir Medical grow rapidly over the years. It is also well-funded, which has allowed it to invest in the expansion of its platform and services, as well as pursue new partnerships to cement its position.
Freddie
Company Specialist at Welcome to the Jungle